The pharmaceutical industry is committed to making a positive impact on the lives of patients while operating sustainably and therefore wants to contribute to a healthy environment and demonstrate leadership in doing what’s necessary to prevent climate disruption. The driving motivation of the pharmaceutical industry is to improve human health and wellbeing. We all need to ensure that the impact of climate change on health is better understood so that we can form and execute our response by understanding the interface between people, health and the environment. We are committed to contribute responsibly to progress in regard to science-based CO2e reduction targets.

This White Paper highlights the commitment made by the EFPIA companies to:

• Establish climate change policies/strategies based on materiality and impact for individual companies;

• Develop actions that support science-based CO2e reduction targets;

• Contribute to increased energy efficiency and aim to use more energy from renewable sources;

• Strive to harmonize GHG reporting based on recognized calculation methodologies and publicly disclose CO2e performance.